Parmeshwar B. Katare
Faridabad, HR 121001, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
The SGLT2 inhibitor empagliflozin promotes increased fatty acid oxidation in skeletal muscle cells.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: May 20, 2025
The use of three-dimensional primary human myospheres to explore skeletal muscle effects of in vivo krill oil supplementation.
Journal: In vitro models
Published: October 31, 2024
Krill oil supplementation in vivo promotes increased fuel metabolism and protein synthesis in cultured human skeletal muscle cells.
Journal: Frontiers in nutrition
Published: June 21, 2024
Divergent effects of monomethyl branched-chain fatty acids on energy metabolism and insulin signaling in human myotubes.
Journal: Journal of lipid research
Published: January 22, 2024
Energy metabolism in skeletal muscle cells from donors with different body mass index.
Journal: Frontiers in physiology
Published: July 01, 2022
Empagliflozin prohibits high-fructose diet-induced cardiac dysfunction in rats via attenuation of mitochondria-driven oxidative stress.
Journal: Life sciences
Published: June 11, 2022
Knockdown of sarcolipin (SLN) impairs substrate utilization in human skeletal muscle cells.
Journal: Molecular biology reports
Published: November 18, 2021
The small molecule SERCA activator CDN1163 increases energy metabolism in human skeletal muscle cells.
Journal: Current research in pharmacology and drug discovery
Published: August 17, 2021
Thrombotic potential during pediatric acute lymphoblastic leukemia induction: Role of cell-free DNA.
Thrombotic potential during pediatric acute lymphoblastic leukemia induction: Role of cell-free DNA.
Journal: Research and practice in thrombosis and haemostasis
Published: April 29, 2021
Paricalcitol Attenuates Metabolic Syndrome-Associated Heart Failure through Enhanced Mitochondrial Fusion.
Journal: Oxidative medicine and cellular longevity
Published: February 05, 2021
Green surfactant-dendrimer aggreplexes: An ingenious way to launch dual attack on arch-enemy cancer.
Green surfactant-dendrimer aggreplexes: An ingenious way to launch dual attack on arch-enemy cancer.
Journal: Colloids and surfaces. B, Biointerfaces
Published: October 29, 2020
pH sensitive liposomes assisted specific and improved breast cancer therapy using co-delivery of SIRT1 shRNA and Docetaxel.
Journal: Materials science & engineering. C, Materials for biological applications
Published: June 21, 2020
Last Updated: 09/26/2026